{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:49:31Z","timestamp":1792097371623,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Open access funding was provided by the Science, Technology & Innovation Funding Authority (STDF) in cooperation with the Egyptian Knowledge Bank (EKB)."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03368-6","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:08:26Z","timestamp":1787987306000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vasopressin boosts the antiproliferative effect of dynasore and wortmannin in triple-negative breast cancer cells"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7303-1444","authenticated-orcid":false,"given":"Samar Sami","family":"AlKafaas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thoria","family":"Diab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samah A","family":"Loutfy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hessien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"key":"3368_CR1","unstructured":"Organization WH: Fact. Sheet Datail of Breast Cancer. 2014. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer. Accessed on 22 June 2021."},{"key":"3368_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/978-1-4615-4871-3_42","volume-title":"Vasopressin and oxytocin: molecular, cellular, and clinical advances","author":"WG North","year":"1998","unstructured":"North WG, Fay MJ, Du J. All three vasopressin receptor sub-types are expressed by small-cell carcinoma. In: Vasopressin and oxytocin: molecular, cellular, and clinical advances. 1998. p. 335\u20138."},{"issue":"6","key":"3368_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063068","volume":"23","author":"M Glava\u0161","year":"2022","unstructured":"Glava\u0161 M, Gitlin-Domagalska A, D\u0119bowski D, Ptaszy\u0144ska N, \u0141\u0119gowska A, Rolka K. Vasopressin and its analogues: from natural hormones to multitasking peptides. Int J Mol Sci. 2022;23(6):3068.","journal-title":"Int J Mol Sci"},{"key":"3368_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10549-005-9024-8","volume":"95","author":"BP Keegan","year":"2006","unstructured":"Keegan BP, Akerman BL, P\u00e9queux C, North WG. Provasopressin expression by breast cancer cells: implications for growth and novel treatment strategies. Breast Cancer Res Treat. 2006;95:265\u201377.","journal-title":"Breast Cancer Res Treat"},{"issue":"24","key":"3368_CR5","first-page":"7882","volume":"50","author":"A Taylor","year":"1990","unstructured":"Taylor A, Ang V, Jenkins J, Silverlight J, Coombes R, Luqmani Y. Interaction of vasopressin and oxytocin with human breast carcinoma cells. Can Res. 1990;50(24):7882\u20136.","journal-title":"Can Res"},{"issue":"2","key":"3368_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/tra.12628","volume":"20","author":"ZY Weinberg","year":"2019","unstructured":"Weinberg ZY, Puthenveedu MA. Regulation of G protein-coupled receptor signaling by plasma membrane organization and endocytosis. Traffic. 2019;20(2):121\u20139.","journal-title":"Traffic"},{"issue":"2","key":"3368_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1124\/mol.116.105064","volume":"91","author":"M Singh","year":"2017","unstructured":"Singh M, Jadhav HR, Bhatt T. Dynamin functions and ligands: classical mechanisms behind. Mol Pharmacol. 2017;91(2):123\u201334.","journal-title":"Mol Pharmacol"},{"key":"3368_CR8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1146\/annurev.biochem.78.081307.110540","volume":"78","author":"GJ Doherty","year":"2009","unstructured":"Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annu Rev Biochem. 2009;78:857\u2013902.","journal-title":"Annu Rev Biochem"},{"issue":"8","key":"3368_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrm2216","volume":"8","author":"S Mayor","year":"2007","unstructured":"Mayor S, Pagano RE. Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol. 2007;8(8):603\u201312.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3368_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-10-78","volume":"10","author":"S Joshi","year":"2011","unstructured":"Joshi S, Braithwaite AW, Robinson PJ, Chircop M. Dynamin inhibitors induce caspase-mediated apoptosis following cytokinesis failure in human cancer cells and this is blocked by Bcl-2 overexpression. Mol Cancer. 2011;10:1\u201312.","journal-title":"Mol Cancer"},{"key":"3368_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-021-02045-y","volume":"40","author":"D Trochet","year":"2021","unstructured":"Trochet D, Bitoun M. A review of dynamin 2 involvement in cancers highlights a promising therapeutic target. J Exp Clin Cancer Res. 2021;40:1\u201312.","journal-title":"J Exp Clin Cancer Res"},{"key":"3368_CR12","first-page":"1423","volume":"19","author":"R Sajed","year":"2020","unstructured":"Sajed R, Zanjani LS, Rahimi M, Mansoori M, Zarnani A-H, Madjd Z, et al. Overexpression and translocation of dynamin 2 promotes tumor aggressiveness in breast carcinomas. EXCLI J. 2020;19:1423.","journal-title":"EXCLI J"},{"issue":"6","key":"3368_CR13","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.devcel.2006.04.002","volume":"10","author":"E Macia","year":"2006","unstructured":"Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T. Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell. 2006;10(6):839\u201350.","journal-title":"Dev Cell"},{"key":"3368_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0076-6879(07)38006-3","volume":"438","author":"T Kirchhausen","year":"2008","unstructured":"Kirchhausen T, Macia E, Pelish HE. Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis. Methods Enzymol. 2008;438:77\u201393.","journal-title":"Methods Enzymol"},{"issue":"10","key":"3368_CR15","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41419-019-1917-2","volume":"10","author":"B Zhong","year":"2019","unstructured":"Zhong B, Shi D, Wu F, Wang S, Hu H, Cheng C, et al. Dynasore suppresses cell proliferation, migration, and invasion and enhances the antitumor capacity of cisplatin via STAT3 pathway in osteosarcoma. Cell Death Dis. 2019;10(10):687.","journal-title":"Cell Death Dis"},{"issue":"12","key":"3368_CR16","doi-asserted-by":"publisher","first-page":"6381","DOI":"10.21873\/anticanres.11235","volume":"36","author":"Y-Y Lee","year":"2016","unstructured":"Lee Y-Y, Jeon H-K, Lee J, Hong JE, Do I-G, Choi CH, et al. Dynamin 2 inhibitors as novel therapeutic agents against cervical cancer cells. Anticancer Res. 2016;36(12):6381\u20138.","journal-title":"Anticancer Res"},{"issue":"1","key":"3368_CR17","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.bbrc.2017.11.109","volume":"495","author":"F Shen","year":"2018","unstructured":"Shen F, Gai J, Xing J, Guan J, Fu L, Li Q. Dynasore suppresses proliferation and induces apoptosis of the non-small-cell lung cancer cell line A549. Biochem Biophys Res Commun. 2018;495(1):1158\u201366.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"3368_CR18","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.4081\/bam.2014.3.217","volume":"24","author":"A Costa","year":"2014","unstructured":"Costa A, Rossi E, Scicchitano BM, Coletti D, Moresi V, Adamo S. Neurohypophyseal hormones: novel actors of striated muscle development and homeostasis. Eur J Transl Myol. 2014;24(3):3790.","journal-title":"Eur J Transl Myol"},{"key":"3368_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.884509","author":"E Hamasaki","year":"2022","unstructured":"Hamasaki E, Wakita N, Yasuoka H, Nagaoka H, Morita M, Takashima E, et al. The lipid-binding defective dynamin 2 mutant in Charcot-Marie-Tooth disease impairs proper actin bundling and actin organization in glomerular podocytes. Front Cell Dev Biol. 2022. https:\/\/doi.org\/10.3389\/fcell.2022.884509.","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"3368_CR20","doi-asserted-by":"publisher","first-page":"429","DOI":"10.4103\/1947-2714.100998","volume":"4","author":"T Mahmood","year":"2012","unstructured":"Mahmood T, Yang PC. Western blot: technique, theory, and trouble shooting. N Am J Med Sci. 2012;4(9):429\u201334.","journal-title":"N Am J Med Sci"},{"issue":"1","key":"3368_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12032-022-01889-4","volume":"40","author":"SS Alkafaas","year":"2022","unstructured":"Alkafaas SS, Loutfy SA, Diab T, Hessien M. Vasopressin induces apoptosis but does not enhance the antiproliferative effect of dynamin 2 or PI3K\/Akt inhibition in luminal A breast cancer cells. Med Oncol (Northwood, London, England). 2022;40(1):35.","journal-title":"Med Oncol (Northwood, London, England)"},{"issue":"suppl_2","key":"3368_CR22","doi-asserted-by":"publisher","first-page":"W270","DOI":"10.1093\/nar\/gkr366","volume":"39","author":"A Grosdidier","year":"2011","unstructured":"Grosdidier A, Zoete V, Michielin O. SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res. 2011;39(suppl_2):W270\u20137.","journal-title":"Nucleic Acids Res"},{"key":"3368_CR23","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.17456.1","author":"JP Rodrigues","year":"2018","unstructured":"Rodrigues JP, Teixeira JM, Trellet M, Bonvin AM. Pdb-tools: a swiss army knife for molecular structures. F1000Res. 2018. https:\/\/doi.org\/10.12688\/f1000research.17456.1.","journal-title":"F1000Res"},{"issue":"W1","key":"3368_CR24","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46(W1):W296\u2013303.","journal-title":"Nucleic Acids Res"},{"key":"3368_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2022.120971","volume":"272","author":"ZH Al-Qaisi","year":"2022","unstructured":"Al-Qaisi ZH, Al-Garawi ZS, Al-Karawi AJM, Hammood AJ, Abdallah AM, Clegg W, et al. Antiureolytic activity of new water-soluble thiadiazole derivatives: spectroscopic, DFT, and molecular docking studies. Spectrochim Acta A Mol Biomol Spectrosc. 2022;272:120971.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"6","key":"3368_CR26","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.3892\/ijo.2015.2952","volume":"46","author":"J Garona","year":"2015","unstructured":"Garona J, Pifano M, Orlando UD, PAsTRIAN MB, Iannucci NB, Ortega HH, et al. The novel desmopressin analogue [V4Q5] dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models. Int J Oncol. 2015;46(6):2335\u201345.","journal-title":"Int J Oncol"},{"issue":"1","key":"3368_CR27","first-page":"30","volume":"14","author":"S Song","year":"2019","unstructured":"Song S, Cong W, Zhou S, Shi Y, Dai W, Zhang H, et al. Small GTPases: structure, biological function and its interaction with nanoparticles. Asian J Pharm Sci. 2019;14(1):30\u20139.","journal-title":"Asian J Pharm Sci"},{"issue":"s1","key":"3368_CR28","doi-asserted-by":"publisher","first-page":"27s","DOI":"10.1111\/j.1469-445X.2000.tb00005.x","volume":"85","author":"WG North","year":"2000","unstructured":"North WG. Gene regulation of vasopressin and vasopressin receptors in cancer. Exp Physiol. 2000;85(s1):27s\u201340s.","journal-title":"Exp Physiol"},{"issue":"6","key":"3368_CR29","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/s41388-019-1059-0","volume":"39","author":"S Sinha","year":"2020","unstructured":"Sinha S, Dwivedi N, Tao S, Jamadar A, Kakade VR, Neil MO, et al. Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy. Oncogene. 2020;39(6):1231\u201345.","journal-title":"Oncogene"},{"key":"3368_CR30","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s10585-016-9799-5","volume":"33","author":"J Garona","year":"2016","unstructured":"Garona J, Pifano M, Pastrian MB, Gomez DE, Ripoll GV, Alonso DF. Addition of vasopressin synthetic analogue [V 4 Q 5] dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models. Clin Exp Metastasis. 2016;33:589\u2013600.","journal-title":"Clin Exp Metastasis"},{"issue":"2","key":"3368_CR31","doi-asserted-by":"publisher","first-page":"F177","DOI":"10.1152\/ajprenal.00431.2012","volume":"304","author":"RL Miller","year":"2013","unstructured":"Miller RL, Sandoval PC, Pisitkun T, Knepper MA, Hoffert JD. Vasopressin inhibits apoptosis in renal collecting duct cells. Am J Physiol Renal Physiol. 2013;304(2):F177\u201388.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"3368_CR32","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1152\/physrev.00035.2011","volume":"92","author":"T-a Koshimizu","year":"2012","unstructured":"Koshimizu T-a, Nakamura K, Egashira N, Hiroyama M, Nonoguchi H, Tanoue A. Vasopressin V1a and V1b receptors: from molecules to physiological systems. Physiol Rev. 2012;92(4):1813\u201364.","journal-title":"Physiol Rev"},{"issue":"3","key":"3368_CR33","doi-asserted-by":"publisher","first-page":"e1148","DOI":"10.1038\/cddis.2014.124","volume":"5","author":"D Hagiwara","year":"2014","unstructured":"Hagiwara D, Arima H, Morishita Y, Wenjun L, Azuma Y, Ito Y, et al. Arginine vasopressin neuronal loss results from autophagy-associated cell death in a mouse model for familial neurohypophysial diabetes insipidus. Cell Death Dis. 2014;5(3):e1148\u2013e1148.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3368_CR34","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.211755","volume":"131","author":"A Persaud","year":"2018","unstructured":"Persaud A, Cormerais Y, Pouyssegur J, Rotin D. Dynamin inhibitors block activation of mTORC1 by amino acids independently of dynamin. J Cell Sci. 2018;131(1):jcs211755.","journal-title":"J Cell Sci"},{"issue":"2","key":"3368_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1247\/csf.10016","volume":"36","author":"N Ishida","year":"2011","unstructured":"Ishida N, Nakamura Y, Tanabe K, Li S-A, Takei K. Dynamin 2 associates with microtubules at mitosis and regulates cell cycle progression. Cell Struct Funct. 2011;36(2):145\u201354.","journal-title":"Cell Struct Funct"},{"issue":"7","key":"3368_CR36","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1021\/bi026807g","volume":"42","author":"TT Schwindt","year":"2003","unstructured":"Schwindt TT, Forti FL, Juliano MA, Juliano L, Armelin HA. Arginine vasopressin inhibition of cyclin D1 gene expression blocks the cell cycle and cell proliferation in the mouse Y1 adrenocortical tumor cell line. Biochemistry. 2003;42(7):2116\u201321.","journal-title":"Biochemistry"},{"key":"3368_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biocel.2018.09.017","volume":"105","author":"T Wang","year":"2018","unstructured":"Wang T, Wang D, Zhang Y, Zhang J, Sun X, Wu Y, et al. Dynasore-induced potent ubiquitylation of the exon 19 deletion mutant of epidermal growth factor receptor suppresses cell growth and migration in non-small cell lung cancer. Int J Biochem Cell Biol. 2018;105:1\u201312.","journal-title":"Int J Biochem Cell Biol"},{"issue":"9","key":"3368_CR38","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1242\/jcs.02963","volume":"119","author":"AE Kruchten","year":"2006","unstructured":"Kruchten AE, McNiven MA. Dynamin as a mover and pincher during cell migration and invasion. J Cell Sci. 2006;119(9):1683\u201390.","journal-title":"J Cell Sci"},{"issue":"1","key":"3368_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12032-022-01889-4","volume":"40","author":"SS Alkafaas","year":"2022","unstructured":"Alkafaas SS, Loutfy SA, Diab T, Hessien M. Vasopressin induces apoptosis but does not enhance the antiproliferative effect of dynamin 2 or PI3K\/Akt inhibition in luminal A breast cancer cells. Med Oncol. 2022;40(1):35.","journal-title":"Med Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03368-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03368-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03368-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:41:49Z","timestamp":1792096909000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03368-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":39,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3368"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03368-6","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol of the current study was approved by the ethical committee of the Faculty of Science, Tanta University (Approval code: 3425\/11\/20).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"263"}}